Directory
>
Jeff Goater
Jeff Goater
Board Member | Remix Therapeutics
Boston, Massachusetts, United States
Jeff Goater
Summary
Jeff Goater is a seasoned professional with extensive experience in the biotechnology and commercial physical research sectors. As a Partner at The Column Group, he plays a pivotal role in guiding emerging biotech companies through critical phases of development. Jeff's background in corporate finance and business development is complemented by his leadership roles on multiple boards, where he leverages his expertise in mergers and acquisitions and venture capital. His academic foundation in pathology and microbiology from the University of Rochester further enhances his insights into the biotech landscape. Known for his strategic thinking, Jeff is passionate about fostering innovation and sustainability in the life sciences. He has been instrumental in navigating complex financial landscapes, making him a valuable asset in any boardroom. Despite his numerous achievements, he remains committed to continuous learning and development within his field.
Jeff Goater
Work Experience
Board Member at
Nilo Therapeutics
July 2024 - Present
Board Member at
Topo Therapeutics, Inc.
July 2024 - Present
Board Member at
Kenai Therapeutics
February 2024 - Present
Partner at
The Column Group
January 2024 - Present
Board Member at
Remix Therapeutics
March 2023 - Present
Chair at
AVIADOBIO LTD
February 2023 - Present
Executive Chair at
Judo Bio
November 2022 - Present
Board Member at
Kallyope
March 2022 - Present
Board Member at
Atavistik Bio
September 2021 - Present
Board Member at
Ribon Therapeutics Inc.
September 2021 - August 2024
Venture Partner at
The Column Group
September 2021 - December 2023
Board Member at
Surface Oncology Inc.
February 2018 - September 2023
Interim CEO at
Atavistik Bio
January 2022 - July 2023
Board Member at
LogicBio Therapeutics
December 2020 - November 2022
Board Member at
Vaccinex
May 2013 - May 2022
CEO at
Surface Oncology Inc.
February 2018 - March 2021
CBO at
Surface Oncology Inc.
February 2017 - February 2018
CFO at
Voyager Therapeutics, Inc.
February 2016 - December 2016
SVP, Finance & Business Development at
Voyager Therapeutics, Inc.
September 2013 - February 2016
VP, Business Development at
Synageva BioPharma Corp.
April 2013 - July 2013
Managing Director at
Evercore
January 2013 - April 2013
VP, Healthcare, M&A Advisory at
Evercore
April 2008 - January 2013
VP, Equity Research, Specialty Pharmaceuticals at
COWEN COMPANY LIMITED
August 2004 - March 2008
Director, Business Development at
Vaccinex
January 2000 - January 2004
Jeff Goater
Education
University of Rochester School of Medicine and Dentistry, Ms
January 2002 - January 2003
University of Rochester - Simon Business School , Mba
January 1998 - January 2000
University of Rochester School of Medicine and Dentistry, Ms
January 1997 - January 2000
January 1993 - January 1997
Frequently Asked Questions about Jeff Goater
What is Jeff Goater email address?
Jeff Goater's primary email address is **********@evercore.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jeff Goater work for?
Jeff Goater is a Board Member at Remix Therapeutics.
Where Jeff Goater graduated from?
Jeff Goater holds a degree in Pathology / Molecular Medicine from University of Rochester School of Medicine and Dentistry.
How can I directly contact Jeff Goater?
To contact Jeff Goater directly, you can use the email address **********@evercore.com. Complete contact information is available upon registration with Muraena.
Who is Jeff Goater?
Jeff Goater is a seasoned professional with extensive experience in the biotechnology and commercial physical research sectors. As a Partner at The Column Group, he plays a pivotal role in guiding emerging biotech companies through critical phases of development. Jeff's background in corporate finance and business development is complemented by his leadership roles on multiple boards, where he leverages his expertise in mergers and acquisitions and venture capital. His academic foundation in pathology and microbiology from the University of Rochester further enhances his insights into the biotech landscape. Known for his strategic thinking, Jeff is passionate about fostering innovation and sustainability in the life sciences. He has been instrumental in navigating complex financial landscapes, making him a valuable asset in any boardroom. Despite his numerous achievements, he remains committed to continuous learning and development within his field.
Jeff`s contact details
**********@evercore.com
*******@remixtx.com
****@kallyope.com
****@thecolumngroup.com
*******@voyagertherapeutics.com
Colleagues
Chief Scientific Officer
Vice President, Head of Program and Alliance Management
Senior Vice President, Head of Early Research
COO/CBO
Sr. Vice President, Clin. Dev. Ops. & Patient Engagement